Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-012789
Filing Date
2023-11-21
Accepted
2023-11-21 21:38:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 31038
2 filename2.txt TEXT-EXTRACT 6976
  Complete submission text file 0000000000-23-012789.txt   50446
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filed for) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: UPLOAD | File No.: 001-38693
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)